Mitochondrial Dysfunction Indirectly Elevates ROS Production by the Endoplasmic Reticulum  by Murphy, Michael P.
Cell Metabolism
PreviewsMitochondrial Dysfunction Indirectly Elevates
ROS Production by the Endoplasmic ReticulumMichael P. Murphy1,*
1MRC Mitochondrial Biology Unit, Hills Road, Cambridge CB2 0XY, UK
*Correspondence: mpm@mrc-mbu.cam.ac.uk
http://dx.doi.org/10.1016/j.cmet.2013.07.006
Mitochondrial dysfunction is often associated with increased reactive oxygen species (ROS) production by
the organelle itself. Leadsham et al. (2013) now show that the link betweenmitochondrial damage and ROS is
more complicated, at least in yeast, where signals from damaged mitochondria increase ROS production
from the endoplasmic reticulum surface.The production of reactive oxygen spe-
cies (ROS) by mitochondria was first
recognized in the 1960s (Jensen, 1966;
Murphy, 2009). Since then, it has become
clear that, in metazoans at least, mito-
chondrial ROS production can occur by
the production of superoxide from com-
plexes I and III, although other sites also
contribute (Murphy, 2009). This superox-
ide production leads to the formation of
hydrogen peroxide, and together with
other downstream products, these ROS
cause nonspecific oxidative damage that
contributes to a number of pathologies
and has also been linked with aging in
general (Harman, 1972; Wallace, 2010).
There is growing evidence that mitochon-
drial ROS production is also involved in
redox signaling (Finkel, 2011), for example
in T cell activation (Sena et al., 2013). One
tacit assumption in all these studies has
been that changes in ROS levels associ-
ated with alterations in mitochondrial
activity are caused by disruption to mito-
chondrial metabolism itself, for example
by the accumulation of NADH in dysfunc-
tional mitochondria (Murphy, 2009). In this
issue of Cell Metabolism, Leadsham et al.
show that the situation is more compli-
cated and present compelling evidence
that while mitochondrial dysfunction in
yeast does increase ROS levels, this is
primarily due to superoxide production
from the surface of the endoplasmic retic-
ulum (ER) and not from the mitochondria
themselves (Leadsham et al., 2013).
When the yeast Saccharomyces
cerevisiae has used up all available
fermentable substrates, such as glucose,
it switches to oxidative metabolism, a
process known as the diauxic shift, which
necessitates the activation of mitochon-
drial metabolism. Leadsham et al. (2013)found that when cytochrome oxidase,
the terminal component of the mitochon-
drial respiratory chain, was inactivated
during the diauxic shift, there was an
increase in ROS that led to a decrease in
cell viability (Figure 1). Surprisingly, further
experiments such as preventing assem-
bly of the respiratory chain by removing
mitochondrial DNA showed that these
ROS were not coming from the mitochon-
dria. In tracking down the ROS source, the
authors came across an unexpected
signaling pathway linking mitochondrial
dysfunction to an elevation of cytosolic
ROS. The first step is the recruitment of
the regulatory GTPase RAS from the
cytosol to the surface of mitochondria.
This localization requires BDF1, which
encodes a bromodomain-containing
TFIID binding protein, although how this
protein acts to recruit RAS to mitochon-
dria remains unclear. The authors next
showed that the source of cytosolic
superoxide and hydrogen peroxide was
the NADPH oxidase Yno1p, which is
found on the surface of the ER. RAS
localization to the outer membrane of
dysfunctional mitochondria somehow
suppresses the activity of the endo-
plasmic reticulum-associated degrada-
tion (ERAD) pathway, an endogenous
protein degradation pathway, which ubiq-
uitinylates proteins for degradation as
part of ER protein quality control. RAS-
dependent suppression of ERAD stabi-
lizes Yno1p to enable the production of
large amounts of superoxide that leads
to decreased cell viability.
As with all surprising results, this work
raises more questions than it answers.
Among these is how mitochondrial dys-
function is sensed. The mitochondrial
damage was initially established byCell Metabolism 1decreasing expression of cytochrome
oxidase. However, the uncoupler FCCP,
which abolishes the mitochondrial pro-
tonmotive force, also led to mitochon-
drial RAS accumulation, suggesting that
disruption to the respiratory chain, by
decreased expression of cytochrome oxi-
dase, leads to defective proton pumping,
which in turn lowers the protonmotive
force. As many types of mitochondrial
damage will lower the protonmotive force,
this is a plausible strategy for sensing
generalized mitochondrial dysfunction.
Furthermore, it has parallels with the
PINK1/Parkin system in mammals, in
whichmitochondriawith lowprotonmotive
force accumulate PINK1 on their surface,
leading to recruitment of the ubiquitin
ligase Parkin that initiates the selective
removal of dysfunctional mitochondria by
mitophagy (Narendra and Youle, 2011).
Future work will explore these parallels in
more detail and will hopefully shed light
on the role of the transcription factor
BDF1 in promoting the recruitment of
RAS to the mitochondrial surface. It may
be that the changes in ROS levels due to
increased Ynop1 activity are important
in shifting the cell to a state that can
better deal with damaged mitochondria,
or perhaps prevents cells with damaged
mitochondria from dividing. In this
regard, NADPH oxidases are involved in
a number of redox signaling pathways
(Finkel, 2011; Gough and Cotter, 2011);
thus changes in ROS production from
Yno1p are a plausible candidate for this
role. However, suppression of ERAD
may also be a consequence of diversion
of the protein turnover machinery to
degrade damaged mitochondria, with the
unintended consequence of increased
activity of Yno1p on the ER surface.8, August 6, 2013 ª2013 Elsevier Inc. 145
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Figure 1. Activation of Endoplasmic Reticulum ROS Production in
Response to Mitochondrial Dysfunction
In this model mitochondrial dysfunction affects the ability of the respiratory
chain to sustain a protonmotive force across the mitochondrial inner mem-
brane, indicated by the positive charge outside the mitochondrion and the
negative charge inside. This leads to the accumulation of the GTPase RAS
on the surface of the mitochondrial outer membrane, which in turn suppresses
the endoplasmic reticulum-associated degradation (ERAD) pathway. As a
consequence, the accumulation of the NADPH oxidase Ynop1 on the surface
of the ER increases the production of superoxide, which is then dismutated
to hydrogen peroxide by superoxide dismutase (SOD). Accumulation of
ROS in response to mitochondrial dysfunction leads to cell death.
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closely this work in yeast
relates to mammalian sys-
tems. There are many sig-
nificant differences between
yeast and mammals, notably
the lack of complex I in
S. cerevisiae, and major dif-
ferences in the mechanisms
of cell death. Even so, the
link between a defect in cyto-
chrome oxidase and an in-
crease in ROS is intriguing,
as decreased activity of this
enzyme has been reported
in a number of neurodegener-
ative diseases (Coskun et al.,
2012). More generally, the
link between cell protein
degradation pathways and
the turnover of damaged
mitochondria is a potentially
fertile area of investigation,
especially as the mitochon-
drial RAS localization has
parallels with the mecha-
nisms disrupted in inherited
forms of Parkinson’s disease
(Coskun et al., 2012; Naren-
dra and Youle, 2011).In conclusion, the work by Leadsham
et al. greatly expands our view of how
mitochondrial dysfunction interacts with
the cell’s redox environment. It is now
clear that an alteration in cytosolic
ROS can be generated indirectly from146 Cell Metabolism 18, August 6, 2013 ª201mitochondrial dysfunction, adding an
interesting new dimension to how mito-
chondrial metabolism links to changes
in ROS. In addition, the specific signal-
ing pathways uncovered in this study
linking mitochondrial dysfunction with3 Elsevier Inc.protein turnover and NADPH
oxidases suggest many new
lines of investigation for ex-
ploring the roles of mitochon-
drial dysfunction in degenera-
tive diseases.
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